Damien McDonald
Net Worth
Last updated:
What is Damien McDonald net worth?
The estimated net worth of Mr. Damien McDonald is at least $20,031,933 as of 30 Mar 2023. He owns shares worth $5,993,881 as insider, has earned $3,798,052 from insider trading and has received compensation worth at least $10,240,000 in LivaNova PLC.
What is the salary of Damien McDonald?
Mr. Damien McDonald salary is $1,280,000 per year as Chief Executive Officer & Director in LivaNova PLC.
How old is Damien McDonald?
Mr. Damien McDonald is 60 years old, born in 1965.
What stocks does Damien McDonald currently own?
As insider, Mr. Damien McDonald owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
LivaNova PLC (LIVN) | Chief Executive Officer & Director | 111,847 | $53.59 | $5,993,881 |
What does LivaNova PLC do?
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Damien McDonald insider trading
LivaNova PLC
Mr. Damien McDonald has made 15 insider trades between 2017-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 43,557 units of LIVN stock on 8 Jun 2018. As of 30 Mar 2023 he still owns at least 111,847 units of LIVN stock.
LivaNova key executives
LivaNova PLC executives and other stock owners filed with the SEC:
- Mr. Alex Shvartsburg (55) Chief Financial Officer and Corporation Vice President of Financial Planning, Analysis & International Region
- Mr. Damien McDonald (60) Chief Executive Officer & Director
- Mr. Marco Dolci (63) Head of Global Operations and R&D
- Ms. Keyna Pidcock Skeffington (62) Senior Vice President, Gen. Counsel & Corporation Sec.